EPS Bio Technology Corp. (TPEX:4183)

EPS Bio Technology Revenue

EPS Bio Technology had revenue of 63.38M TWD in the quarter ending March 31, 2026, a decrease of -49.28%. This brings the company's revenue in the last twelve months to 443.44M, down -7.26% year-over-year. In the year 2025, EPS Bio Technology had annual revenue of 499.70M with 10.78% growth.

• Revenue (ttm): 443.44M
• Revenue Growth: -7.26%
• P/S Ratio: 0.75
• Revenue / Employee: 4.07M
• Employees: 109
• Market Cap: 333.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	499.70M	48.62M	10.78%
Dec 31, 2024	451.08M	-19.08M	-4.06%
Dec 31, 2023	470.17M	6.72M	1.45%
Dec 31, 2022	463.45M	-16.83M	-3.50%
Dec 31, 2021	480.28M	2.68M	0.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error